Markowitz J - Search Results

1

Use of infliximab in the treatment of Crohn's disease in children and adolescents.

Hyams JS, Markowitz J, Wyllie R. Hyams JS, et al. Among authors: markowitz j. J Pediatr. 2000 Aug;137(2):192-6. doi: 10.1067/mpd.2000.107161. J Pediatr. 2000. PMID: 10931411 Clinical Trial.

2

Clinical outcome of ulcerative colitis in children.

Hyams JS, Davis P, Grancher K, Lerer T, Justinich CJ, Markowitz J. Hyams JS, et al. Among authors: markowitz j. J Pediatr. 1996 Jul;129(1):81-8. doi: 10.1016/s0022-3476(96)70193-2. J Pediatr. 1996. PMID: 8757566

3

Clinical outcome of ulcerative proctitis in children.

Hyams J, Davis P, Lerer T, Colletti RB, Bousvaros A, Leichtner A, Benkov K, Justinich C, Markowitz J. Hyams J, et al. Among authors: markowitz j. J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):149-52. doi: 10.1097/00005176-199708000-00004. J Pediatr Gastroenterol Nutr. 1997. PMID: 9252900

4

Characterization of hepatic abnormalities in children with inflammatory bowel disease.

Hyams J, Markowitz J, Treem W, Davis P, Grancher K, Daum F. Hyams J, et al. Among authors: markowitz j. Inflamm Bowel Dis. 1995 Spring;1(1):27-33. Inflamm Bowel Dis. 1995. PMID: 23283310

5

Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis.

Markowitz J, Kahn E, Grancher K, Hyams J, Treem W, Daum F. Markowitz J, et al. Am J Gastroenterol. 1993 Dec;88(12):2034-7. Am J Gastroenterol. 1993. PMID: 8249970

6

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.

Turner D, Leach ST, Mack D, Uusoue K, McLernon R, Hyams J, Leleiko N, Walters TD, Crandall W, Markowitz J, Otley AR, Griffiths AM, Day AS. Turner D, et al. Among authors: markowitz j. Gut. 2010 Sep;59(9):1207-12. doi: 10.1136/gut.2010.211755. Gut. 2010. PMID: 20801771

7

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.

Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN. Stephens MC, et al. Am J Gastroenterol. 2003 Jan;98(1):104-11. doi: 10.1111/j.1572-0241.2003.07161.x. Am J Gastroenterol. 2003. PMID: 12526944

8

Infliximab as a novel therapy for pediatric ulcerative colitis.

Mamula P, Markowitz JE, Brown KA, Hurd LB, Piccoli DA, Baldassano RN. Mamula P, et al. J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):307-11. doi: 10.1097/00005176-200203000-00017. J Pediatr Gastroenterol Nutr. 2002. PMID: 11964959

9

Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab.

Miele E, Markowitz JE, Mamula P, Baldassano RN. Miele E, et al. J Pediatr Gastroenterol Nutr. 2004 May;38(5):502-8. doi: 10.1097/00005176-200405000-00008. J Pediatr Gastroenterol Nutr. 2004. PMID: 15097438 Free article.

10

Infliximab in pediatric ulcerative colitis: two-year follow-up.

Mamula P, Markowitz JE, Cohen LJ, von Allmen D, Baldassano RN. Mamula P, et al. Among authors: markowitz je. J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):298-301. doi: 10.1097/00005176-200403000-00013. J Pediatr Gastroenterol Nutr. 2004. PMID: 15076630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

991 results

Search Page

Filters